Sign up USA
Proactive Investors - Run By Investors For Investors
Market: CSE
52-week High/Low: C$1.13 / C$0.06
Sector: Pharmaceuticals
Market Cap: C$100.58M
Abattis Bioceuticals

Abattis Bioceuticals

Abattis Bioceuticals Corp. provides patented equipment and consulting services to the hemp, medicinal and adult marijuana markets.  The company is positioned to capitalize on the growing trend toward marijuana legalization in the United States and medicinal use in Canada and international jurisdictions by supplying or partnering with companies to employ its vertical growing systems, extraction equipment/technology, and other forms of support to licensed growers and distributors.  The company also has an extensive pipeline of high-quality products and technologies for growing and extraction in the rapidly expanding botanical drug market.

Abattis Bioceuticals

Interactive graph

col 3
col 4
col 5
col 6

Abattis Bioceuticals Timeline

Copyright ©, 2017. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use